Soltani Sepideh, Fallah Tina, Shafiei Morvarid, Shahraki Abdolrazagh Hashemi, Iranbakhsh Alireza
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran; Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
Department of Biology, Faculty of Science, Alzahra University, Tehran, Iran; Department of Bacteriology, Pasteur Institute of Iran, Tehran, Iran.
J Glob Antimicrob Resist. 2025 Apr 29;43:344-357. doi: 10.1016/j.jgar.2025.04.022.
Enterococcus faecalis and Enterococcus faecium are Gram-positive opportunistic pathogens that rank among the leading causes of nosocomial infections worldwide. This study investigates the prevalence and role of CRISPR-Cas systems in modulating antimicrobial resistance and virulence factors in clinical isolates of E. faecalis and E. faecium collected from patients in Tehran, Iran.
A total of 75 clinical isolates of E. faecalis and E. faecium were collected from various hospitals in Tehran, Iran, between January and April 2023, from adult patients with urinary tract infections (n = 55), blood infections (n = 12), and wound infections (n = 8). Conventional bacteriology tests and PCR were used to isolate and identify Enterococcus species. Phenotypic antibiotic and genotypic resistance were assessed. CRISPR-Cas repeat-spacer array were screened using PCR, and the relationship between CRISPR-Cas systems and antibiotic resistance and virulence genes was statistically analyzed. Phylogenetic, structural, and conservation analyses were performed to assess the degree of conservation in CRISPR1-Cas csn1 and CRISPR3-Cas csn1 genes, identify potential mutations, and evaluate their possible impact on Cas9 protein function.
86.6% of the isolates harbored CRISPR-Cas repeat-spacer array, with a significantly higher prevalence in E. faecalis than in E. faecium (100% vs. 66.6%, P = 0.0001). CRISPR1-Cas, CRISPR2, and CRISPR3-Cas loci were identified in 76%, 82.6%, and 64% of isolates, respectively. Notably, the prevalence of CRISPR-Cas systems was significantly reduced in extensively drug-resistant (XDR) isolates (32%) compared to multidrug-resistant (MDR) isolates (68%, P = 0.0001). Conservation analyses of CRISPR1-Cas csn1 and CRISPR3-Cas csn1 genes revealed conserved regions potentially linked to functional activity. Furthermore, CRISPR-Cas repeat-spacer array were correlated with specific antimicrobial resistance phenotypes and genotypes, as well as with virulence factors.
These findings suggest that CRISPR-Cas systems may influence the resistance and virulence profiles of clinical Enterococcus isolates, potentially impacting their pathogenicity and adaptability.
粪肠球菌和屎肠球菌是革兰氏阳性机会致病菌,是全球医院感染的主要原因之一。本研究调查了CRISPR-Cas系统在调节从伊朗德黑兰患者中分离出的粪肠球菌和屎肠球菌临床分离株的抗菌耐药性和毒力因子方面的流行情况及作用。
2023年1月至4月期间,从伊朗德黑兰的多家医院收集了75株粪肠球菌和屎肠球菌临床分离株,这些分离株来自患有尿路感染(n = 55)、血液感染(n = 12)和伤口感染(n = 8)的成年患者。采用常规细菌学检测和PCR方法分离和鉴定肠球菌种类。评估表型抗生素耐药性和基因型耐药性。使用PCR筛选CRISPR-Cas重复间隔序列阵列,并对CRISPR-Cas系统与抗生素耐药性和毒力基因之间的关系进行统计分析。进行系统发育、结构和保守性分析,以评估CRISPR1-Cas csn1和CRISPR3-Cas csn1基因的保守程度,识别潜在突变,并评估其对Cas9蛋白功能的可能影响。
86.6%的分离株携带CRISPR-Cas重复间隔序列阵列,粪肠球菌中的流行率显著高于屎肠球菌(100%对66.6%,P = 0.0001)。分别在76%、82.6%和64%的分离株中鉴定出CRISPR1-Cas、CRISPR2和CRISPR3-Cas位点。值得注意的是,与多重耐药(MDR)分离株(68%,P = 0.0001)相比,广泛耐药(XDR)分离株中CRISPR-Cas系统的流行率显著降低(32%)。CRISPR1-Cas csn1和CRISPR3-Cas csn1基因的保守性分析揭示了可能与功能活性相关的保守区域。此外,CRISPR-Cas重复间隔序列阵列与特定的抗菌耐药表型和基因型以及毒力因子相关。
这些发现表明,CRISPR-Cas系统可能影响临床肠球菌分离株的耐药性和毒力特征,可能影响其致病性和适应性。